Progressive Vaccinia Acquired through Zoonotic Transmission in a Patient with HIV/AIDS, Colombia
Katherine Laiton-Donato
1
, Paola Ávila-Robayo
1, Andrés Páez-Martinez, Paula Benjumea-Nieto, José A. Usme-Ciro, Nicole Pinzón-Nariño, Ivan Giraldo, Diego Torres-Castellanos, Yoshinori Nakazawa, Nishi Patel, Kimberly Wilkins, Yu Li, Whitni Davidson, Jillybeth Burgado, Panayampalli Subbian Satheshkumar, Ashley Styczynski, Matthew R. Mauldin, Martha Gracia-Romero, and Brett W. Petersen
Author affiliations: Instituto Nacional de Salud, Bogotá, Colombia (K. Laiton-Donato, J.A. Usme-Ciro, M. Gracia-Romero); Hospital Universitario Mayor Méderi-Universidad del Rosario, Bogotá (P. Ávila-Robayo, P. Benjumea-Nieto, N. Pinzón-Nariño, I. Giraldo, D. Torres-Castellanos); Universidad de La Salle, Bogotá (A. Páez-Martínez); Universidad Cooperativa de Colombia, Santa Marta, Colombia (J.A. Usme-Ciro); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (Y. Nakazawa, N. Patel, K. Wilkins, Y. Li, W. Davidson, J. Burgado, P.S. Satheshkumar, A. Styczynski, M.R. Mauldin, B.W. Petersen)
Main Article
Table
Laboratory testing for orthopoxvirus diagnosis in an HIV/AIDS patient who acquired progressive vaccinia through zoonotic transmission, Colombia*
Sample date and type
|
Serology
|
|
PCR
|
Viral culture
|
IgM ELISA
|
IgG ELISA
|
Neutralization
titer
|
OPXV-specific (Ct)
|
Vaccinia-specific
|
2015 Mar |
|
Serum |
Pos |
Pos |
1:517 |
|
|
|
|
Scab |
|
|
|
|
Pos (31.9) |
Pos |
Pos |
Scab
|
|
|
|
|
Pos (28.6)
|
Pos
|
Pos
|
2015 Jul |
|
Serum |
Neg |
Pos |
1:223 |
|
|
|
|
Scab, left leg |
|
|
|
|
Pos (36.2) |
Pos |
Pos† |
Swab, left leg
|
|
|
|
|
Pos (29.2)
|
Pos
|
Pos†
|
2016 Apr |
|
Paraffin block, left leg |
|
|
|
|
Neg |
|
|
Paraffin block, left leg |
|
|
|
|
Neg |
|
|
Paraffin block, left leg |
|
|
|
|
Neg |
|
|
Main Article
Page created: February 20, 2020
Page updated: February 20, 2020
Page reviewed: February 20, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.